Positive survey results have helped push Supernus Pharmaceutical Inc (NASDAQ: SUPN) up in Thursday trading and fueled an upgrade from Piper Jaffray.
Latest Ratings for SUPN
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 2017 | PiperJaffray | Upgrades | Neutral | Overweight |
| Dec 2016 | Cantor Fitzgerald | Initiates Coverage On | Overweight | |
| Aug 2016 | Jefferies | Maintains | Buy |
View More Analyst Ratings for SUPN
View the Latest Analyst Ratings
June 02, 2017 at 12:28AM
from Merrick Weingarten
No comments:
Post a Comment